G-CSF Administration Is Associated with Worse Treatment Response and Survival after CAR T-Cell Therapy

Autor: Bindal, Poorva, Elavalakanar, Pavania ^*, Trottier, Caitlin A. ^*, Dodge, Laura E. ^*, Logan, Emma K. ^*, Sermer, David J., Leukam, Michael, Weinstock, Matthew J, Joyce, Robin M., Liegel, Jessica, Rosenblatt, Jacalyn, Avigan, David, Alonso, Carolyn D. ^*, Arnason, Jon E.

Publikováno v: In Blood 15 November 2022 140 Supplement 1:5238-5240

Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia

Autor: Castillo, Jorge J., Sarosiek, Shayna, Branagan, Andrew R., Sermer, David J., Flynn, Catherine A. ^*, Leventoff, Carly ^*, Little, Megan ^*, White, Timothy P ^*, Meid, Kirsten ^*, Canning, Alexa ^*, Guerrera, Maria Luisa, Kofides, Amanda ^*, Liu, Xia ^*, Munshi, Manit ^*, Tsakmaklis, Nicholas ^*, Patterson, Christopher J ^*, Hunter, Zachary R, Treon, Steven P

Publikováno v: In Blood 15 November 2022 140 Supplement 1:564-565

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Herpes Simplex Encephalitis as a Complication of Whole-Brain Radiotherapy: A Case Report and Review of the Literature.

Autor: Sermer, David J., Woodley, Jamie L., Thomas, Christian A., Hedlund, Jacquelyn A.

Publikováno v: Case Reports in Oncology; Sep-Dec2014, Vol. 7 Issue 3, p774-779, 6p

Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy.

Autor: Fernandez Turizo MJ; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Kim E; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, United States., Zhang C; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Yankama T; Department of Data Analytics and Biostatistics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Von Keudell G; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Sermer DJ; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Mejías-De Jesús C; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, United States., Asnani A; Cardio-Oncology Section, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Publikováno v: The oncologist [Oncologist] 2024 Sep 08. Date of Electronic Publication: 2024 Sep 08.